3A
General Information
DCTPep ID DCTPep00270
Peptide Name 3A
Sequence LTAEHYAAQATS
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin E3 ubiquitin-protein ligase
Type Synthetic peptide
Classification
Cancer targeted peptides Affect cell cycle
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
-- | -- | IC50 for MDM2>100 µM | ELISA assay | Not available | 1 |
-- | -- | IC50 for MDMX-p53>100 µM | ELISA assay | Not available | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target MDM2
Affinity Not available
Mechanism Inhibits MDM2-p53 Interaction
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C54H83N15O20
Absent amino acids CDFGIKMNPRVW
Theoretical pI 5.24
Acidic residues 1
Basic residues 1
Polar residues 4
Molecular weight (Average) 1262.34
Molecular weight (Monoisotopic) 1261.59
Common amino acids A
Net charge 0
Instability index (II) 59.23
Aliphatic index 65.83
Grand average of hydropathicity (GRAVY) -0.225
Half Life
5.5 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Ext. coefficient 1490
Abs 0.1% (=1 g/l) 1.180
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21423613
Title mRNA display selection of an optimized MDM2-binding peptide that potently inhibits MDM2-p53 interaction
Doi 10.1371/journal.pone.0017898
Year 2011
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available